Tonix prices 615,025 shares at $16.26 in registered direct offering

20 hours ago 3

TipRanks

Tue, December 30, 2025 astatine 7:00 AM CST 1 min read

Tonix Pharmaceuticals (TNXP) entered into a securities acquisition statement with Point72 for the acquisition and merchantability of 615,025 shares of its communal banal astatine an offering terms of $16.26 per stock and, successful lieu of shares of communal stock, pre-funded warrants to acquisition up to an aggregate of 615,025 shares of communal banal astatine a acquisition terms of $16.259 per pre-funded warrant, which equals the offering terms per stock of the communal banal little the $0.001 per stock workout terms of each pre-funded warrant. The closing of the offering is expected to instrumentality spot connected oregon astir December 30, taxable to the restitution of customary closing conditions. The gross proceeds of the offering volition beryllium astir $20M earlier deducting placement cause fees and different estimated offering expenses payable by the Company. TD Cowen is acting arsenic sole placement cause for the offering. A.G.P./Alliance Global Partners is acting arsenic a fiscal advisor.

Unlock hedge fund-level information and almighty investing tools for smarter, sharper decisions
Stay up of the marketplace with the latest quality and investigation and maximize your portfolio's potential

Published archetypal connected TheFly – the eventual root for real-time, market-moving breaking fiscal news. Try Now>>

See today’s best-performing stocks connected TipRanks >>

Read More connected TNXP:

Disclaimer & DisclosureReport an Issue

Tonix Pharmaceuticals announces update connected Phase 2/3-ready TNX-4800
Tonix Pharma Secures Rights to TNX-4900 for Pain Management
Tonix Pharmaceuticals announces licensing worldwide rights to TNX-4900
Tonix Pharma Appoints New General Counsel
Tonix Pharmaceuticals appoints Ishak arsenic General Counsel

Read Entire Article